Literature DB >> 20968151

Manual for coding and reporting haematological malignancies.

.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20968151

Source DB:  PubMed          Journal:  Tumori        ISSN： 0300-8916            Impact factor:   2.098


× No keyword cloud information.
  8 in total

1.  Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Authors:  Eric W Tai; Kevin C Ward; Audrey Bonaventure; David A Siegel; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

2.  Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.

Authors:  Rafael Marcos-Gragera; Claudia Allemani; Carmen Tereanu; Roberta De Angelis; Riccardo Capocaccia; Marc Maynadie; Stefano Luminari; Stefano Ferretti; Tom Børge Johannesen; Risto Sankila; Marja-Liisa Karjalainen-Lindsberg; Arianna Simonetti; Maria Carmen Martos; Martine Raphaël; Pilar Giraldo; Milena Sant
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

3.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

4.  Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN).

Authors:  Marcela Guevara; Amaia Molinuevo; Diego Salmerón; Rafael Marcos-Gragera; Marià Carulla; María-Dolores Chirlaque; Marta Rodríguez Camblor; Araceli Alemán; Dolores Rojas; Ana Vizcaíno Batllés; Matilde Chico; Rosario Jiménez Chillarón; Arantza López de Munain; Visitación de Castro; Maria-José Sánchez; Enrique Ramalle-Gómara; Paula Franch; Jaume Galceran; Eva Ardanaz
Journal:  Cancers (Basel)       Date:  2022-05-15       Impact factor: 6.575

5.  Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Authors:  Audrey Bonaventure; Rhea Harewood; Charles A Stiller; Gemma Gatta; Jacqueline Clavel; Daniela C Stefan; Helena Carreira; Devon Spika; Rafael Marcos-Gragera; Rafael Peris-Bonet; Marion Piñeros; Milena Sant; Claudia E Kuehni; Michael F G Murphy; Michel P Coleman; Claudia Allemani
Journal:  Lancet Haematol       Date:  2017-04-11       Impact factor: 18.959

6.  The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study.

Authors:  Enza Di Felice; Francesca Roncaglia; Francesco Venturelli; Lucia Mangone; Stefano Luminari; Claudia Cirilli; Giuliano Carrozzi; Paolo Giorgi Rossi
Journal:  BMC Cancer       Date:  2018-11-06       Impact factor: 4.430

7.  Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.

Authors:  Claudia Vener; Silvia Rossi; Pamela Minicozzi; Rafael Marcos-Gragera; Hélène A Poirel; Marc Maynadié; Xavier Troussard; Gabriella Pravettoni; Roberta De Angelis; Milena Sant
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

8.  Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Authors:  Eve Roman; Alex Smith; Simon Appleton; Simon Crouch; Richard Kelly; Sally Kinsey; Catherine Cargo; Russell Patmore
Journal:  Cancer Epidemiol       Date:  2016-04-16       Impact factor: 2.984
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.